Transplacental RNAi: deciphering gene function in the postimplantation-staged embryo

• Published in: Journal of biomedicine & biotechnology Vol. 2006; no. 4; pp. 18657 - 12
• Main Authors: O'shea, K Sue, De Boer, Lisa S, Slawny, Nicole A, Gratsch, Theresa E
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 2006; Hindawi Publishing Corporation
• Subjects: Gene silencing; Gene targeting; Genetic aspects; Ovum implantation; Review; United States
• ISSN: 1110-7243; 1110-7251
• DOI: 10.1155/jbb/2006/18657

RNAi offers the opportunity to examine the role in postimplantation development of genes that cause preimplantation lethality and to create allelic series of targeted embryos. We have delivered constituitively expressed short hairpin (sh) RNAs to pregnant mice during the early postimplantation period of development and observed gene knockdown and defects that phenocopy the null embryo. We have silenced genes that have not yet been "knocked out" in the mouse (geminin and Wnt8b), those required during earlier cleavage stages of development (nanog), and genes required at implantation (Bmp4, Bmp7) singly and in combination (Bmp4 + Bmp7), and obtained unique phenotypes. We have also determined a role in postimplantation development of two transcripts identified in a differential display RT-PCR screen of genes induced in ES cells by noggin exposure, Aggf1 and an Est (GenBank AK008955). Systemic delivery of shRNAs provides a valuable approach to gene silencing in the embryo.